187 related articles for article (PubMed ID: 23108737)
1. Medication exposure in pregnancy risk evaluation program: the prevalence of asthma medication use during pregnancy.
Hansen C; Joski P; Freiman H; Andrade S; Toh S; Dublin S; Cheetham C; Cooper W; Pawloski P; Li DK; Beaton S; Kaplan S; Scott P; Hammad T; Davis R
Matern Child Health J; 2013 Nov; 17(9):1611-21. PubMed ID: 23108737
[TBL] [Abstract][Full Text] [Related]
2. Poorly Controlled Asthma During Pregnancy Remains Common in the United States.
Cohen JM; Bateman BT; Huybrechts KF; Mogun H; Yland J; Schatz M; Wurst KE; Hernandez-Diaz S
J Allergy Clin Immunol Pract; 2019; 7(8):2672-2680.e10. PubMed ID: 31257187
[TBL] [Abstract][Full Text] [Related]
3. Risk of congenital anomalies after exposure to asthma medication in the first trimester of pregnancy - a cohort linkage study.
Garne E; Vinkel Hansen A; Morris J; Jordan S; Klungsøyr K; Engeland A; Tucker D; Thayer DS; Davies GI; Nybo Andersen AM; Dolk H
BJOG; 2016 Sep; 123(10):1609-18. PubMed ID: 27172856
[TBL] [Abstract][Full Text] [Related]
4. Impact of maternal use of asthma-controller therapy on perinatal outcomes.
Cossette B; Forget A; Beauchesne MF; Rey É; Lemière C; Larivée P; Battista MC; Blais L
Thorax; 2013 Aug; 68(8):724-30. PubMed ID: 23585516
[TBL] [Abstract][Full Text] [Related]
5. Beta2-agonists use during pregnancy and the risk of congenital malformations.
Eltonsy S; Forget A; Blais L
Birth Defects Res A Clin Mol Teratol; 2011 Nov; 91(11):937-47. PubMed ID: 21948561
[TBL] [Abstract][Full Text] [Related]
6. Effect of maternal asthma on the risk of specific congenital malformations: A population-based cohort study.
Blais L; Kettani FZ; Elftouh N; Forget A
Birth Defects Res A Clin Mol Teratol; 2010 Apr; 88(4):216-22. PubMed ID: 20099316
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of asthma during pregnancy].
Vroegop JS; Aalbers R; van Loon AJ
Ned Tijdschr Geneeskd; 2009; 153():B361. PubMed ID: 19785846
[TBL] [Abstract][Full Text] [Related]
8. The prevalence and trends of antiviral medication use during pregnancy in the US: a population-based study of 664,297 deliveries in 2001-2007.
Avalos LA; Chen H; Yang C; Andrade SE; Cooper WO; Cheetham CT; Davis RL; Dublin S; Hammad TA; Kaplan S; Pawloski PA; Raebel MA; Scott PE; Smith DH; Toh S; Li DK
Matern Child Health J; 2014 Jan; 18(1):64-72. PubMed ID: 23420306
[TBL] [Abstract][Full Text] [Related]
9. Perinatal outcomes in women with asthma during pregnancy.
Alexander S; Dodds L; Armson BA
Obstet Gynecol; 1998 Sep; 92(3):435-40. PubMed ID: 9721785
[TBL] [Abstract][Full Text] [Related]
10. Maternal asthma medication use and the risk of selected birth defects.
Lin S; Munsie JP; Herdt-Losavio ML; Druschel CM; Campbell K; Browne ML; Romitti PA; Olney RS; Bell EM;
Pediatrics; 2012 Feb; 129(2):e317-24. PubMed ID: 22250027
[TBL] [Abstract][Full Text] [Related]
11. Maternal asthma, asthma medication use, and the risk of congenital heart defects.
Lin S; Herdt-Losavio M; Gensburg L; Marshall E; Druschel C
Birth Defects Res A Clin Mol Teratol; 2009 Feb; 85(2):161-8. PubMed ID: 19067406
[TBL] [Abstract][Full Text] [Related]
12. Asthma prevalence among women aged 18 to 44 in the United States: National health and nutrition examination survey 2001-2016.
Flores KF; Bandoli G; Chambers CD; Schatz M; Palmsten K
J Asthma; 2020 Jul; 57(7):693-702. PubMed ID: 31014137
[No Abstract] [Full Text] [Related]
13. Cessation of asthma medication in early pregnancy.
Enriquez R; Wu P; Griffin MR; Gebretsadik T; Shintani A; Mitchel E; Carroll KN; Hartert TV
Am J Obstet Gynecol; 2006 Jul; 195(1):149-53. PubMed ID: 16631099
[TBL] [Abstract][Full Text] [Related]
14. [The management of bronchial asthma during pregnancy--Hungarian experiences].
Tamási L; Bohács A; Pállinger E; Rigó J; Magyar P; Losonczy G
Orv Hetil; 2005 Nov; 146(45):2305-9. PubMed ID: 16304809
[TBL] [Abstract][Full Text] [Related]
15. Medication Exposure in Pregnancy Risk Evaluation Program.
Andrade SE; Davis RL; Cheetham TC; Cooper WO; Li DK; Amini T; Beaton SJ; Dublin S; Hammad TA; Pawloski PA; Raebel MA; Smith DH; Staffa JA; Toh S; Dashevsky I; Haffenreffer K; Lane K; Platt R; Scott PE
Matern Child Health J; 2012 Oct; 16(7):1349-54. PubMed ID: 22002179
[TBL] [Abstract][Full Text] [Related]
16. Risk of perinatal mortality associated with inhaled corticosteroid use for the treatment of asthma during pregnancy.
Breton MC; Beauchesne MF; Lemière C; Rey É; Forget A; Blais L
J Allergy Clin Immunol; 2010 Oct; 126(4):772-777.e2. PubMed ID: 20920768
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: a population-based study of 585,615 deliveries.
Toh S; Li Q; Cheetham TC; Cooper WO; Davis RL; Dublin S; Hammad TA; Li DK; Pawloski PA; Pinheiro SP; Raebel MA; Scott PE; Smith DH; Bobo WV; Lawrence JM; Dashevsky I; Haffenreffer K; Avalos LA; Andrade SE
Arch Womens Ment Health; 2013 Apr; 16(2):149-57. PubMed ID: 23389622
[TBL] [Abstract][Full Text] [Related]
18. Prescription medication use and baseline health status of women with live-birth deliveries in a national data network.
Suarez EA; Haug N; Hansbury A; Stojanovic D; Corey C
Am J Obstet Gynecol MFM; 2022 Jan; 4(1):100512. PubMed ID: 34656737
[TBL] [Abstract][Full Text] [Related]
19. Controller Medication Use and Exacerbations for Children and Adults With Asthma in High-Deductible Health Plans.
Galbraith AA; Ross-Degnan D; Zhang F; Wu AC; Sinaiko A; Peltz A; Xu X; Wallace J; Wharam JF
JAMA Pediatr; 2021 Aug; 175(8):807-816. PubMed ID: 33970186
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacological treatment of asthma during pregnancy].
van Nederveen-Bendien SA; van Oord-Bosselaar SRJ; Feitsma AH; Kappen JH
Ned Tijdschr Geneeskd; 2018; 162():D2099. PubMed ID: 29519258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
